🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

4 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
40% Evidence Coverage

Supplement Facts — Evidence Check

ChromeMate
250 mcg (714% DV)
2000 mg
📊 Market median: 550.0mg (217 products) 📚 29 studies (Tier A: 0, B: 5)
This product: 2000mg
Chasteberry Fruit Extract
400 mg
📊 Market median: 200.0mg (198 products) 📚 6 studies — no high-quality reviews
This product: 250mg
100 mg
📊 Market median: 100.0mg (283 products) 📚 142 studies (Tier A: 1, B: 64)
This product: 100mg UL 1200mg

Other Ingredients

Hypromellose Microcrystalline Cellulose Leucine

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (78% of products) Nutrient (22% of products)

Target Groups

Vegetarian Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, take 4 capsules daily, or as directed by your healthcare practitioner.

⚠️ Warnings & Precautions

Warning: Do not take if pregnant, nursing or planning to become pregnant. If you have any pre-existing conditions or are taking any medications consult your healthcare practitioner before using.

Keep out of reach of children.

🧪 Formulation Notes

Truth We pledge total truth in labeling. Our family of products contains only the purest and most potent ingredients. Guaranteed. Color of this product may vary due to color variations of the natural ingredients.

A Dietary Supplement to support hormone balance and healthy ovarian function

Vegetarian

Gluten free Soy free

Additional Information

Store in a cool, dry place.

Product Details

UPC / SKU 0 26664 01787 1
DSLD Entry Date 2024-09-25
Product Type Other Combinations
Form Capsule
DSLD ID 318960
Data Updated 2026-04-11

Research Evidence

32 Research Sources
50 Avg Quality Score
19 Rct
7 Meta Analysis
3 Clinical Trial
2 Other
1 Systematic Review
B Greater Choline-Containing Compounds and Myo-inositol in Treatment-Resistant Versus Responsive Schizophrenia: A 1H-Magnetic Resonance Spectroscopy Meta-analysis
Meta Analysis Biological psychiatry. Cognitive neuroscience and neuroimaging 2024
B Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines
Meta Analysis The Journal of clinical endocrinology and metabolism 2024
B Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes
Meta Analysis The Cochrane database of systematic reviews 2023
B Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis
Meta Analysis Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2022
B Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis
Meta Analysis Irish journal of medical science 2023
B Inositol for subfertile women with polycystic ovary syndrome
Meta Analysis The Cochrane database of systematic reviews 2018
B Treatment of lean PCOS teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives
Rct European review for medical and pharmacological sciences 2021
B The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios
Rct European review for medical and pharmacological sciences 2019
C Investigating the effect of combined use of selenium and Myo-inositol supplements on thyroid function and autoimmune characteristics in thyroid disorders: a systematic review and meta-analysis
Meta Analysis Expert review of endocrinology & metabolism 2024
C Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial.
Rct International journal of food sciences and nutrition
View all evidence for Inositol →

Compare Similar Products

View all Inositol products →